Acurx Pharmaceuticals, Inc. Diluted Shares Outstanding (Weighted Average)
Acurx Pharmaceuticals, Inc. (ACXP) reported Diluted Shares Outstanding (Weighted Average) of 4.26 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 4.26M shares, a 257.86% increase year-over-year.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 2.72M shares, a 171.32% increase year-over-year.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 2.17M shares, a 156.16% increase year-over-year.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 1.63M shares, a 98.71% increase year-over-year.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.50M shares, a 85.46% increase from fiscal 2024.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 808.17K shares, a 93.62% decline from fiscal 2023.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 12.67M shares, a 17.15% increase from fiscal 2022.
- Acurx Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 10.82M shares, a 26.72% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.26M shares 10-Q · filed 2026-08-13 | 3.49M shares 10-Q · filed 2026-08-13 | 3.05M shares derived: average of 3 quarters · filed 2026-08-13 | 2.69M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 2.72M shares 10-Q · filed 2026-05-11 | 2.44M shares derived: average of 2 quarters · filed 2026-05-11 | 2.17M shares derived: average of 3 quarters · filed 2026-05-11 | 1.93M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 2.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.90M shares derived: average of 2 quarters · filed 2026-03-12 | 1.66M shares derived: average of 3 quarters · filed 2026-08-13 | 1.50M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 1.63M shares 10-Q · filed 2025-11-12 | 1.41M shares derived: average of 2 quarters · filed 2026-08-13 | 1.28M shares 10-Q · filed 2025-11-12 | 1.17M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 1.19M shares 10-Q · filed 2026-08-13 | 1.10M shares 10-Q · filed 2026-08-13 | 1.01M shares derived: average of 3 quarters · filed 2026-08-13 | 964.22K shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 1.00M shares 10-Q · filed 2026-05-11 | 20.04M shares 10-Q · filed 2025-05-12 | 924.22K shares derived: average of 2 quarters · filed 2026-05-11 | 888.87K shares derived: average of 3 quarters · filed 2026-05-11 | 864.46K shares derived: average of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | 846.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 832.34K shares derived: average of 2 quarters · filed 2026-03-12 | 818.64K shares derived: average of 3 quarters · filed 2026-03-12 | 808.17K shares 10-K · filed 2026-03-12 | 16.16M shares 10-K · filed 2025-03-17 | |||
| 2024-09-30 | 818.17K shares 10-Q · filed 2025-11-12 | 16.36M shares 10-Q · filed 2024-11-12 | 804.70K shares derived: average of 2 quarters · filed 2025-11-12 | 795.39K shares 10-Q · filed 2025-11-12 | 15.91M shares 10-Q · filed 2024-11-12 | 7.73M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 791.23K shares 10-Q · filed 2025-08-11 | 15.82M shares 10-Q · filed 2024-08-08 | 783.87K shares 10-Q · filed 2025-08-11 | 15.68M shares 10-Q · filed 2024-08-08 | 10.03M shares derived: average of 3 quarters · filed 2025-08-11 | 10.78M shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 15.47M shares 10-Q · filed 2025-05-12 | 14.66M shares derived: average of 2 quarters · filed 2025-05-12 | 14.11M shares derived: average of 3 quarters · filed 2025-05-12 | 13.63M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 13.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 13.42M shares derived: average of 2 quarters · filed 2025-03-17 | 13.01M shares derived: average of 3 quarters · filed 2025-03-17 | 12.67M shares 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | 13.01M shares 10-Q · filed 2024-11-12 | 12.60M shares derived: average of 2 quarters · filed 2024-11-12 | 12.28M shares 10-Q · filed 2024-11-12 | 12.11M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 12.19M shares 10-Q · filed 2024-08-08 | 11.91M shares 10-Q · filed 2024-08-08 | 11.81M shares derived: average of 3 quarters · filed 2024-08-08 | 11.65M shares derived: average of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 11.64M shares 10-Q · filed 2024-05-14 | 11.63M shares derived: average of 2 quarters · filed 2024-05-14 | 11.47M shares derived: average of 3 quarters · filed 2024-05-14 | 11.17M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 11.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 11.38M shares derived: average of 2 quarters · filed 2024-03-15 | 11.01M shares derived: average of 3 quarters · filed 2024-03-15 | 10.82M shares 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | 11.15M shares 10-Q · filed 2023-11-13 | 10.71M shares derived: average of 2 quarters · filed 2023-11-13 | 10.55M shares 10-Q · filed 2023-11-13 | 10.46M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 10.26M shares 10-Q · filed 2023-08-11 | 10.25M shares 10-Q · filed 2023-08-11 | 10.22M shares derived: average of 3 quarters · filed 2023-08-11 | 10.20M shares derived: average of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | 10.23M shares 10-Q · filed 2023-05-12 | 10.21M shares derived: average of 2 quarters · filed 2023-05-12 | 10.18M shares derived: average of 3 quarters · filed 2023-05-12 | 9.37M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 10.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 10.15M shares derived: average of 2 quarters · filed 2023-03-15 | 9.09M shares derived: average of 3 quarters · filed 2023-03-15 | 8.54M shares 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | 10.12M shares 10-Q · filed 2022-11-10 | 8.54M shares derived: average of 2 quarters · filed 2022-11-10 | 7.99M shares 10-Q · filed 2022-11-10 | 7.65M shares derived: average of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | 6.97M shares 10-Q · filed 2022-08-12 | 6.91M shares 10-Q · filed 2022-08-12 | 6.83M shares derived: average of 3 quarters · filed 2022-08-12 | 6.69M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | 6.87M shares 10-Q · filed 2022-05-10 | 6.76M shares derived: average of 2 quarters · filed 2022-05-10 | 6.60M shares derived: average of 3 quarters · filed 2022-05-10 | |||||
| 2020-12-31 | 6.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | 6.46M shares derived: average of 2 quarters · filed 2022-03-16 | 6.19M shares 10-K · filed 2022-03-16 | |||||
| 2020-09-30 | 6.27M shares 10-Q · filed 2021-11-12 | 6.04M shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |